Transurban Group (ASX: TCL)- ACCC paves the way to Transurban’s WestConnex bid

Transurban Group (ASX: TCL)

ACCC gives a green card to the bid proposed by TCL led consortium for the acquisition of majority interest in the WestConnex motorway, following the acceptance of detailed undertaking published by Transurban group.

Transurban Group is a lead member of Sydney Transport Partners consortium that has applied for acquisition of WestConnex, a partially completed motorway development in Sydney. Following to this bid rival bidder ACCC had asked TCL to publish detailed toll traffic data for all roads in New South Wales as it was believed to have advantage over future toll road concessions in NSW.

[optin-monster-shortcode id=”wxhmli4jjedneglg1trq”]

Stating competition concerns on Transurban already holding majority interest in 7 out of 9 toll roads in Sydney, ACCC Chair Rod Sim said the key issue was whether WestConnex acquisition would further entrench their position.

But in the investigation focused on future competition, ACCC found that the majority of Transurban’s traffic data is publicly available and not exclusive. “They are satisfied that with this undertaking others will be able to compete for new toll road concessions in New South Wales if Transurban succeeds in its bid for WestConnex” said Sim.

With this update TCL edged up 1.933% to $12.130 on 30 August 2018.

Dividend Stocks To Buy

The Income available from dividends remains attractive for many investors.

We take a look at the best yields on the market and assess what they say about a company’s prospect.

One Thing is certain, though, Australia interest rates are still low, making income difficult to come by and keeping the focus for many investors on high yielding stocks. Kalkine’s team of analysts bought you handpicked report for “Top 25 Dividend Stocks For 2018.”

ASX-relevant Special Reports are published year-round to provide a detailed analysis into an investing opportunity or a potential risk to your portfolio.

Click here to get your free report.


The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.

Join Our Discussion

Start discussion with value Investors for ASX Stock Market Investment and Opinion.

6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report